IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 155 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $205,000 | +54.1% | 7,402 | +1.4% | 0.00% | 0.0% |
| Q3 2019 | $133,000 | -29.6% | 7,300 | -5.2% | 0.00% | 0.0% |
| Q2 2019 | $189,000 | +195.3% | 7,700 | +14.9% | 0.00% | – |
| Q1 2019 | $64,000 | +1.6% | 6,700 | -6.5% | 0.00% | -100.0% |
| Q4 2018 | $63,000 | -31.5% | 7,168 | -12.2% | 0.00% | 0.0% |
| Q3 2018 | $92,000 | -4.2% | 8,168 | +43.3% | 0.00% | 0.0% |
| Q2 2018 | $96,000 | 0.0% | 5,700 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $96,000 | +380.0% | 5,700 | +135.1% | 0.00% | – |
| Q4 2017 | $20,000 | +11.1% | 2,425 | +9.0% | 0.00% | – |
| Q3 2017 | $18,000 | +5.9% | 2,225 | 0.0% | 0.00% | – |
| Q2 2017 | $17,000 | – | 2,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |